Dunder K - Search Results

1

Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.

Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B. Ekeblad S, et al. Among authors: dunder k. Clin Cancer Res. 2008 Dec 1;14(23):7798-803. doi: 10.1158/1078-0432.CCR-08-0734. Clin Cancer Res. 2008. PMID: 19047107

2

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Ekeblad S, Sundin A, Janson ET, Welin S, Granberg D, Kindmark H, Dunder K, Kozlovacki G, Orlefors H, Sigurd M, Oberg K, Eriksson B, Skogseid B. Ekeblad S, et al. Among authors: dunder k. Clin Cancer Res. 2007 May 15;13(10):2986-91. doi: 10.1158/1078-0432.CCR-06-2053. Clin Cancer Res. 2007. PMID: 17505000

3

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years.

Kindmark H, Sundin A, Granberg D, Dunder K, Skogseid B, Janson ET, Welin S, Oberg K, Eriksson B. Kindmark H, et al. Among authors: dunder k. Med Oncol. 2007;24(3):330-7. doi: 10.1007/s12032-007-0011-2. Med Oncol. 2007. PMID: 17873310

4

Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study.

Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Dunder K, et al. BMJ. 2003 Mar 29;326(7391):681. doi: 10.1136/bmj.326.7391.681. BMJ. 2003. PMID: 12663403 Free PMC article.

5

Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM).

Dunder K, Lind L, Zethelius B, Berglund L, Lithell H. Dunder K, et al. Am Heart J. 2004 Oct;148(4):596-601. doi: 10.1016/j.ahj.2004.03.021. Am Heart J. 2004. PMID: 15459588

6

A new Q/QS pattern on the resting electrocardiogram is associated with impaired insulin secretion and a poor prognosis in elderly men independently of history of myocardial infarction.

Dunder K, Lind L, Zethelius B, Lithell H. Dunder K, et al. J Intern Med. 2004 Feb;255(2):221-8. doi: 10.1046/j.1365-2796.2003.01285.x. J Intern Med. 2004. PMID: 14746559 Free article.

7

Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.

Dunder K, Lind L, Lagerqvist B, Zethelius B, Vessby B, Lithell H. Dunder K, et al. Am Heart J. 2004 Mar;147(3):502-8. doi: 10.1016/j.ahj.2003.09.010. Am Heart J. 2004. PMID: 14999201

8

Pancreatic safety of incretin-based drugs--FDA and EMA assessment.

Egan AG, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, Rosebraugh C. Egan AG, et al. Among authors: dunder k. N Engl J Med. 2014 Feb 27;370(9):794-7. doi: 10.1056/NEJMp1314078. N Engl J Med. 2014. PMID: 24571751 Free article. No abstract available.

9

The European Medicines Agency's approval of new medicines for type 2 diabetes.

Blind E, Janssen H, Dunder K, de Graeff PA. Blind E, et al. Among authors: dunder k. Diabetes Obes Metab. 2018 Sep;20(9):2059-2063. doi: 10.1111/dom.13349. Epub 2018 May 30. Diabetes Obes Metab. 2018. PMID: 29740935 Free PMC article. Review.

10

Comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al.

Dunder K, de Graeff PA, Blind E. Dunder K, et al. Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):129. doi: 10.1093/ehjcvp/pvx006. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28444250 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters